Scientists test if you can take new pill with breakfast
NCT ID NCT07329972
Summary
This early-stage study aims to understand how eating food and taking a common stomach acid medicine (rabeprazole) affect how the body absorbs a new drug called ZN-A-1041. It will involve 48 healthy volunteers who will take the drug under different conditions (like with a high-fat meal or after the stomach medicine). The main goal is to gather basic safety data and see how these factors change the drug's levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Daytona Beach Clinical Rsch Unit
RECRUITINGDaytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit - Dallas
RECRUITINGDallas, Texas, 75247-4989, United States
Conditions
Explore the condition pages connected to this study.